Oil Majors Post Staggering Profits as Corporate America Reshapes Through Earnings and Layoffs

INTRODUCTION

The August 1, 2026 session is defined by a convergence of Q2 2026 corporate earnings releases and strategic workforce restructuring that together illuminate divergent dynamics across US sectors. The most commanding catalyst is the energy sector, where ExxonMobil (XOM) reported profits that more than doubled during Q2 2026 and Chevron (CVX) saw profits more than quadruple over the same period. Exxon CEO Darren Woods tempered consumer hopes for lower gasoline prices, stating plainly that he would not hold his breath for relief at the pump. Simultaneously, Visa announced plans to lay off 7% of its workforce, intending to redirect the savings toward business areas it views as having strong potential, a move framed against an impressive prior quarter for its value-added initiatives. In regulated utilities, IDACORP (IDA) beat earnings expectations and raised guidance. PBF Energy (PBF) surprised on margins and throughput, while Iovance Biotherapeutics (IOVA) heads into its earnings report with its T cell therapy story and valuation under scrutiny. Collectively, these developments paint a picture of an earnings season marked by outsized energy profits, disciplined corporate cost management, and sector-specific valuation debates.

FUTURE PROJECTIONS

BEST CASE:

Energy companies sustain their profit trajectories, supporting broad index earnings growth, while Visa's reallocation of savings from layoffs into high-potential business lines — building on its already impressive value-added initiatives — accelerates revenue diversification. IDACORP's raised guidance proves conservative, and PBF Energy's margin and throughput beats signal a durable refining upcycle. In this scenario, equity markets are projected to grind higher on earnings momentum, with energy and payments sectors leading.

BASE CASE:

Oil majors' profit surge proves partly cyclical, and Exxon CEO Darren Woods's warning that consumers should not expect lower gasoline prices suggests elevated energy costs persist, creating a modest headwind for consumer spending. Visa's layoffs improve operating leverage but markets treat the restructuring as already priced into the stock. IDACORP's upside is debated as potentially fully valued after its guidance raise. PBF Energy faces questions about whether its stock is fully priced following its beats. Iovance draws attention but remains a show-me story until earnings confirm the commercial trajectory of its T cell therapy.

WORST CASE:

Sustained high energy prices, as signaled by Woods's comments, begin to weigh on consumer confidence and compress margins for energy-intensive sectors. Visa's layoffs are read as a sign of slowing core payment volumes rather than strategic reallocation. IDACORP and PBF Energy both suffer from a market perception that upside is already priced in, triggering sell-the-news reactions. Iovance disappoints on earnings, calling into question the commercial viability of its therapy at current valuations.

HISTORICAL CONTEXT

The energy sector's profit explosion in Q2 2026 — with Exxon more than doubling and Chevron more than quadrupling profits — marks a notable acceleration in an already robust earnings cycle for oil majors. The scale of Chevron's profit growth is particularly striking and suggests structural or pricing conditions that have favored integrated producers. Darren Woods's candid dismissal of near-term gasoline price relief underscores the industry's posture of capital discipline and shareholder returns over volume expansion, a strategic stance that has defined the post-2020 era for major oil companies. In payments, Visa's prior quarter demonstrated the impressive success of its value-added initiatives, providing a foundation for the company to pursue deeper workforce optimization while simultaneously reinvesting in growth.

PRIMARY STAKEHOLDERS

Darren Woods, CEO of ExxonMobil, is the most prominent voice in today's cycle, explicitly managing consumer expectations by warning against hopes for cheaper gasoline even as his company reports massive profit growth. Visa's management is executing a dual strategy of cost reduction through a 7% workforce cut and reinvestment, signaling confidence in specific growth vectors tied to its value-added services. IDACORP's leadership has raised guidance following a Q2 beat, positioning the utility as a steady-growth narrative. PBF Energy's management delivered on margins and throughput but faces the market's valuation question. Iovance Biotherapeutics draws investor focus ahead of earnings, with its T cell therapy story central to the investment case.

ECONOMIC IMPLICATIONS

The staggering profit growth at Exxon and Chevron has direct implications for the energy weighting in US equity indices and for consumer-facing sectors that absorb higher fuel costs. Woods's comments suggest no near-term commodity price relief, which could pressure consumer discretionary spending and keep energy inflation elevated. Visa's restructuring and reinvestment may support fintech and payments sector sentiment. IDACORP's raised guidance reinforces the defensive appeal of regulated utilities. PBF Energy's margin beats spotlight the refining subsector. Iovance's upcoming earnings represent a bellwether for biotech sentiment around commercial-stage cell therapies.